1-OHPGb | Ncases | Ncontrols | Unadjusted OR (95% CI) | Adjusted OR (95% CI) c |
---|---|---|---|---|
Colorectal cancer | ||||
Q1: <0.10 | 89 | 86 | Ref | Ref |
Q2: ≥0.10 to <0.196 | 100 | 86 | 1.11 (0.74-1.68) | 1.11 (0.73-1.71) |
Q3: ≥0.196 to <0.331 | 80 | 86 | 0.89 (0.58-1.37) | 0.88 (0.56-1.38) |
Q4: ≥0.331 | 74 | 85 | 0.84 (0.55-1.30) | 0.85 (0.54-1.33) |
P trend = 0.3 | P trend = 0.3 | |||
Per 1-unit increase in 1-OHPGd | 0.98 (0.95-1.02) | 0.98 (0.95-1.02) | ||
Colon cancer | ||||
Q1: <0.10 | 54 | 48 | Ref | Ref |
Q2: ≥0.10 to <0.196 | 59 | 53 | 0.96 (0.56-1.64) | 0.93 (0.53-1.65) |
Q3: ≥0.196 to <0.331 | 50 | 51 | 0.84 (0.47-1.50) | 0.77 (0.41-1.46) |
Q4: ≥0.331 | 42 | 53 | 0.70 (0.39-1.24) | 0.69 (0.40-1.29) |
P trend = 0.2 | P trend = 0.2 | |||
Per 1-unit increase in 1-OHPGd | 0.98 (0.93-1.03) | 0.98 (0.93-1.03) | ||
Rectal cancer | ||||
Q1: <0.10 | 35 | 38 | Ref | Ref |
Q2: ≥0.10 to <0.196 | 41 | 33 | 1.35 (0.70-2.61) | 1.43 (0.70-2.93) |
Q3: ≥0.196 to <0.331 | 30 | 35 | 0.95 (0.49-1.83) | 0.93 (0.46-1.87) |
Q4: ≥0.331 | 32 | 32 | 1.08 (0.56-2.09) | 1.09 (0.54-2.21) |
P trend = 0.9 | Ptrend = 0.9 | |||
Per 1-unit increase in 1-OHPGd | 0.99 (0.92-1.07) | 0.98 (0.91-1.07) |